Login
$ANIP
$70.84 -$0.60 (0.84%) Live

$ANIP 8-K/A SEC Filings

Filed On Filing
08 Aug 2022 8-K/A: Costs Associated with Exit or Disposal Activities

On June 2, 2022, ANI Pharmaceuticals, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Prior 8-K”) announcing its decision to cease operations at its manufacturing plant located in Oakville, Ontario, Canada as part of ongoin...

16 Aug 2016 8-K/A: Regulation FD Disclosure

A Specialty Pharmaceutical Company NASDAQ: ANIP GENERIC AND BRANDED PRESCRIPTION DRUG PRODUCTS Corporate Presentation August 2016

27 Oct 2014 8-K/A: Results of Operations and Financial Condition

BAUDETTE, Minnesota (October 27, 2014) – ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its third quarter and year-to-date 2014 financial results on Monday, November 3, 2014, before the opening...

27 Jun 2013 8-K/A: Financial Statements and Exhibits

We have audited the accompanying balance sheet of ANIP Acquisition Company (d/b/a ANI Pharmaceuticals, Inc.) (the “Company”) as of December 31, 2012, and the related statements of operations, changes in redeemable convertible preferred s...

07 Jun 2010 8-K/A: Other Events

[Portions of this Exhibit have been omitted pursuant to a request for confidentiality under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. The confidential portions of this Exhibit that have been omitted are marked with “...

19 Sep 2003 8-K/A: Other Events

On August 6, 2003, BioSante Pharmaceuticals, Inc. issued a press release, a copy of which is attached hereto, announcing the completion of a private placement of an aggregate of 4,791,982 shares of its common stock and warrants to purcha...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support